Finance

Beta
Lists
600867:SHA
Tonghua Dongbao Pharmaceutical Co Ltd
CN¥7.38
-2.64%
(-0.20) 1D
Jun 11, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600867...
Open
CN¥7.53
High
CN¥7.58
Low
CN¥7.35
Mkt. cap
14.73B
Avg. vol.
30.79M
Volume
15.44M
Dividend
4.07%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jun 5, 2026
P/E ratio
11.75
52-wk high
CN¥10.67
52-wk low
CN¥7.35
EPS
CN¥0.63
Shares outstanding
2.03B
No. of employees
3K
Open
CN¥7.53
High
CN¥7.58
Low
CN¥7.35
Mkt. cap
14.73B
Avg. vol.
30.79M
Volume
15.44M
Dividend
4.07%
Quarterly dividend
CN¥0.07
Ex-dividend date
Jun 5, 2026
P/E ratio
11.75
52-wk high
CN¥10.67
52-wk low
CN¥7.35
EPS
CN¥0.63
Shares outstanding
2.03B
No. of employees
3K
News stories
From sources across the web
About Tonghua Dongbao Pharmaceutical Co Ltd
CEO-
Employees3.35K
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitethdb.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
721.99M
806.10M
767.64M
747.65M
Cost of goods sold
-
220.63M
273.45M
212.16M
Cost of revenue
-
220.63M
273.45M
212.16M
Research and development expenses
-
35.78M
50.69M
35.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
344.63M
275.71M
337.36M
Operating expense
-
390.97M
336.75M
377.09M
Total operating expenses
-
611.59M
610.21M
589.25M
Operating income
-
194.50M
157.43M
158.40M
Other non operating income
-
-19.21M
-701.80K
-138.08K
EBT including unusual items
-
1.17B
36.69M
166.32M
EBT excluding unusual items
-
1.28B
159.07M
167.61M
Income tax expense
-
206.00M
27.37M
44.93M
Effective tax rate
-
17.67%
74.60%
27.01%
Other operating expenses
-
10.67M
10.44M
2.16M
Net income
-
984.48M
16.82M
126.80M
Net profit margin
-
122.13%
2.19%
16.96%
Earnings per share
-
-
-
-
Interest and investment income
-
1.11B
8.08M
13.26M
Interest expense
-
-5.68M
-5.12M
-3.91M
Net interest expenses
-
1.10B
2.96M
9.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
241.25M
223.00M
223.97M
Gain or loss from assets sale
-
1.74K
3.12M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more